Gene polymorphism of adiponectin in restenosis after coronary stenting

Eur Rev Med Pharmacol Sci. 2019 Aug;23(3 Suppl):287-293. doi: 10.26355/eurrev_201908_18659.

Abstract

Objective: The objective of the present study was to investigate the relationship between adiponectin (APN)+45T/G and +276G/T polymorphisms and in-stent restenosis (ISR).

Patients and methods: A total of 150 patients treated with percutaneous coronary intervention (PCI) were divided into the ISR group and non-ISR group. The levels of blood biochemical indicators were measured, and APN+45T/G and +276G/T polymorphisms were detected by TaqMan probes.

Results: Cholesterol levels in the IRS group were significantly higher than those in the non-ISR group (p<0.05). The frequency of the GG genotype and G allele of the APN+45T/G locus in the ISR group were significantly higher than those in the non-ISR group (p<0.05). The frequency of the GG genotype and G allele of the APN+276G/T locus in the ISR group were significantly higher than those in the non-ISR group (p<0.05).

Conclusions: APN+45T/G and +276G/T polymorphisms were associated with susceptibility to ISR, and carrying the G allele of the APN+45T/G and +276G/T loci can significantly increase the risk of ISR.

MeSH terms

  • Adiponectin / genetics*
  • Aged
  • Case-Control Studies
  • Cholesterol / blood
  • Coronary Restenosis / etiology
  • Coronary Restenosis / genetics*
  • Coronary Restenosis / metabolism
  • Craniosynostoses
  • Female
  • Genetic Association Studies
  • Genetic Testing
  • Holoprosencephaly
  • Humans
  • Male
  • Middle Aged
  • Percutaneous Coronary Intervention / instrumentation
  • Polymorphism, Genetic*
  • Stents / adverse effects*

Substances

  • ADIPOQ protein, human
  • Adiponectin
  • Cholesterol

Supplementary concepts

  • Genoa syndrome